Search Orphan Drug Designations and Approvals
-
Generic Name: | Octreotide (acetate) |
---|---|
Date Designated: | 06/30/2022 |
Orphan Designation: | Treatment of carcinoid syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Chiesi USA, Inc. 175 Regency Woods Place, Suite 600 Cary, North Carolina 27518 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-